Peripheral Interventions Market analysis research and trends report for 2020-2026
Category: #business  By Rahul Varpe  Date: 2020-03-26
  • share
  • Twitter
  • Facebook
  • LinkedIn
Peripheral Interventions Market analysis research and trends report for 2020-2026

Peripheral Interventions Market is expected to exceed USD 10 billion by 2025. Growing preference towards minimally invasive treatments and rising burden of cardiovascular disease will impel the demand for peripheral vascular devices.

Some major findings of the peripheral interventions market report include:

  • The demand for drug-eluting stents and aspiration catheters is increasing across the globe due to benefits such as greater strength and flexibility, that aids in treating complex lesions
  • Technological developments majorly in the developed countries of North America and Asia Pacific is estimated to drive the peripheral intervention market expansion
  • Increasing integration of catheterization laboratories with novel devices including robotic systems by hospitals will augment peripheral interventions market growth
  • Boston Scientific Corporation is among the top industry players owing to robust investment in product innovation and expansion in interventional oncology segment

Request sample copy of this report @ https://www.decresearch.com/request-sample/detail/2915

High incidence of cardiovascular disorders will significantly impact the peripheral disease treatment market in the near future. Rising prevalence of coronary heart disease, cerebrovascular disease and peripheral artery disease (PAD) will lead to greater peripheral vascular device adoption. Risk factors such as smoking, unhealthy lifestyle, atherosclerosis, and hypertension will further contribute peripheral intervention market growth. Additionally, due to comorbidities of peripheral artery disease and complexities, balloon angioplasty and stenting devices will foresee substantial demand in the upcoming years.

Rapidly advancing technologies in vascular intervention systems will yield competitive market growth opportunities. Leading market players offering advanced minimally invasive devices such as drug-eluting stents, drug-coated balloons, catheters, guidewires, etc. coupled with superior benefits have substantially increased the procedural success rate. For instance, Xience Sierra introduced by Abbott is the newest stent technology, offering various benefits such as flexibility, long length, small diameter and greater compatibility. Thus, rising demand for minimally invasive processes, advancements, and growing expenditure on R&D, will lead to notable development in peripheral vascular devices in the foreseeable future.

However, high cost of peripheral intervention devices and lack of knowledge regarding treatment and diagnosis of peripheral diseases will restrict the market growth.

Make Inquiry about this report @ https://www.decresearch.com/inquiry-before-buying/2915

Guide wires product segment is expected to show significant growth owing to growing incidence of target diseases such as ischemic heart disease, nephrolithiasis and brain aneurysm. Also, increase in application of guidewires in neurovascular and peripheral interventions is also among key factors assisting the segment expansion. In addition, technology breakthroughs in accessibility, affordability, enhanced flexibility coupled with minimal deformity and exemplary tip shape retention are key factors that will drive the segmental size in the forthcoming years.

Atherosclerosis application segment is forecasted to expand at significant pace over the analysis period. Atherosclerosis is directly associated with consumption of high fat dietary habit and smoking. Thus, growing epidemiology of hypertension and atherosclerosis coupled with rising risk factors leading to rapid disease development will impact the application of peripheral vascular devices for atherosclerosis. Furthermore, rising approval and increase in the R&D for treatment of atherosclerosis are some of the major factors contributing to the segmental growth over the forecast period.

Peripheral interventions market in hospitals accounted for highest revenue share in 2018. Increasing patient pool suffering from cardiovascular diseases, thereby increasing hospitalizations, will positively impact the segmental size. Availability of technologically advanced devices coupled with favorable reimbursement policies in hospitals will further boost business growth during the analysis period. Furthermore, advanced healthcare infrastructure, assisting set-up of catheter laboratory will boost hospitals segment expansion in the upcoming years.

Canada peripheral interventions market will witness substantial growth in foreseeable future. Growing geriatric population, adoption of peripheral intervention device coupled with advanced medical treatment pattern will act as positively influencing factor for the market growth. Furthermore, presence of large patient pool, undiagnosed with PAD, and presence of improving peripheral intervention infrastructure will offer robust expansion opportunities in the country.

China peripheral interventions market is forecasted to progress at more than 8.5% CAGR over the estimation timeframe. Rising population undertaking smoking, increasing the risk of CVDs, coupled with growing geriatric population base will majorly offer opportunities for market growth. In addition, rising number of hospitals equipped with catheterization laboratories and government funding in the country will serve to be positive influencing factors for market expansion.

Market players are focusing on geographical expansion by adopting various strategies such as acquisitions, mergers, strategic collaborations and partnership to gain significant revenue share and sustain industrial competition. In September 2019, OrbusNeich Medical K.K., a Japanese firm, declared that the Japan Ministry of Health, Labour, and Welfare has approved the COMBO Plus Coronary Stent. The pioneer drug-eluting stent couples the patented endothelial progenitor cell capture technology with an abluminal sirolimus drug elution dispensed from a biodegradable matrix polymer. Such approvals will facilitate robust industry expansion in the foreseeable future.

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Rahul Varpe

Rahul Varpe    

Rahul Varpe currently writes for Technology Magazine. A communication Engineering graduate by education, Rahul started his journey in as a freelancer writer along with regular jobs. Rahul has a prior experience in writing as well as marketing of services and products ...

Read More >>

More News By Rahul Varpe

Dental Practice Management Software Market is set to record 11.8% CAGR during forecast time
Dental Practice Management Software Market is set to record 11.8% CAGR during forecast time
By Rahul Varpe

The size of the Dental Practice Management Software Market was accrued at USD 1.2 billion in 2018 and is presumed to accumulate over USD 2.7 billion by the year 2025. According to research, the Dental Practice Management Software Market is expected t...

By 2025, Biosensors Market is Expected to Record 31.5 Billion Dollar Revenue
By 2025, Biosensors Market is Expected to Record 31.5 Billion Dollar Revenue
By Rahul Varpe

The Biosensors Market size was estimated at USD 18.6 billion in 2018 and is projected to surpass USD 31.5 billion by the year 2025. During the period of 2019-2025, the Biosensors Market is anticipated to expand with a CAGR of 8%. The report contain...

Breast Pump Market Recent Trends and Forecast To 2025
Breast Pump Market Recent Trends and Forecast To 2025
By Rahul Varpe

The Breast Pump Market is projected to expand from its present industry value of over $1 billion to more than $1.5 billion over the analysis timeframe. According to the study with title ‘Global Breast Pump Market Research Report’, the g...